Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycystic Ovary Syndrome × Tirzepatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 9 Endometrial Neoplasms 4 Prostatic Neoplasms 2 Overweight 2 Diabetes Mellitus 2 Breast Neoplasms 2 Weight Loss 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Opioid-Related Disorders 1 Metabolic Syndrome 1 Lymphoma, Follicular 1 Insulin Resistance 1 Inflammation 1 Hyperplasia 1 Endometrial Hyperplasia 1 Dyslipidemias 1 Colorectal Neoplasms 1

Interventions

Metformin 135 Clomiphene 43 Letrozole 35 Inositol 25 Folic Acid 17 Exercise 17 Progesterone 16 Ethinyl Estradiol 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Estradiol 12 Contraceptives, Oral 11 cetrorelix 10 High-Intensity Interval Training 10 Chorionic Gonadotropin 10 Triptorelin Pamoate 9 Tablets 9 Pioglitazone 9 Spironolactone 8 Diet 8 Cholecalciferol 8 Vitamin D 7 Thioctic Acid 7 Surveys and Questionnaires 7 Menotropins 7 Liraglutide 7 Gonadotropins 7 Acupuncture Therapy 7 drospirenone 6 Ovidrel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07326111 2026-01-08

PERIODS

University of Bonn

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡